Product Name:

NebuPeptide™ Insulin Lispro (Peptide Reference)

Catalog Number:

NBS-233761

Description:

NebuPeptide™ Insulin Lispro (Peptide Reference)(CAT#NBS-233761) is synthesized in accordance with the Insulin Lispro sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Liraglutide reference peptide ranging from milligrams to kilograms.

Peptide Name:

Insulin Lispro

Background:

Insulin lispro is a recombinant human insulin analogue and one of the three fast acting insulin analogues. Insulin lispro can be used in the study of diabetes hyperglycemia.

Alias:

N/A

CAS Number:

133107-64-9

Formula:

C257H383N65O77S6

Molecular Weight:

5807.63

Purity:

see COA

Solubility:

see COA

Storage & Shipment:

Store at -20℃; ship with blue ice.

For R&D use only!

To get more information, please contact us freely.